Request Deal Involvement
Eli Lilly completed the acquisition of POINT Biopharma for $1.4bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Centerview Partners
legal advisors
Skadden Arps Slate Meagher & Flom
legal advisors to financial advisors
Cooley
financial advisors
Goldman Sachs
legal advisors
Kirkland & Ellis
or
Principals
target
POINT BIOPHARMA
bidder
ELI LILLY AND COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite